Compare Nokia Corp (NOK) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nokia Corp vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Nokia Corp trades at $10.34 (market cap $60.13B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Nokia Corp is far larger — about 26.4× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Nokia Corp pays a 1.54% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| NOK | SLS | |
|---|---|---|
Market Cap | $60.13B | $2.28B |
Volume | 71,806,452 | 3,128,960 |
Sector | Technology | Health |
52-Week High | $16.83 | $15.46 |
52-Week Low | $5.18 | $1.39 |
Typical Hold Time | 66 Days | — |
Enterprise Value | $58.14B | $2.15B |
Dividend Yield | 1.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nokia (NOK) trades at $10.14, down 7.57% over the past day, with a bullish technical signal from moving averages. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. Revenue for 2025 was $19.89 billion with a net income margin of 3.47%. Recent news highlights partnerships with Microsoft and ICEYE for AI and satellite communications, driving positive sentiment.
The outlook is supported by strong analyst consensus with a $17.50 price target and 61.5% buy ratings, but risks include volatile cash flows and high valuation multiples. Upside potential exists from AI infrastructure demand, while execution and competitive pressures remain key concerns for investors.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nokia Corp
Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
